Fawell Stephen 4
4 · C4 Therapeutics, Inc. · Filed Sep 3, 2024
Insider Transaction Report
Form 4
Fawell Stephen
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-08-29+65,000→ 65,000 totalExercise: $6.43Exp: 2034-08-28→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]33% of the shares underlying this option shall vest and become exercisable on August 29, 2025, with the remainder vesting in eight equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.